FDA Inspection 1226825 — Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd.
The FDA completed an inspection of Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd. on Dec 1, 2023 in Shiyan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 1, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shiyan (China)